Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can special lenses put the brakes on childhood myopia?

NCT ID NCT05840185

Terminated Disease control Sponsor: Essilor International Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This trial tests whether a new type of spectacle lens can slow the progression of myopia (nearsightedness) in children aged 8 to 13. Over 12 months, researchers measure changes in eye length and prescription, comparing results to a historical group that wore standard lenses. The goal is to find a simple, everyday solution to reduce worsening eyesight in kids.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
special myopia control spectacle lenses (DAL) worn for 12 months
What this could lead to
If effective, these lenses could offer a simple, non-invasive way to slow worsening nearsightedness in children, reducing the risk of severe eye problems later in life.
What could go wrong
This is a small, early study with only 40 children and no control group—results are compared to a historical group from another trial, which may not be reliable. The lenses may not slow myopia significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

eye disorder myopia refractive error

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA

Contacts and locations

Locations

  • Essilor R&D Centre Singapore

    Singapore, 339346, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.